Literature DB >> 19824921

Efficiency of T-cell costimulation by CD80 and CD86 cross-linking correlates with calcium entry.

Markus Thiel1, Melodie-Jo Wolfs, Stefan Bauer, Anna S Wenning, Tanja Burckhart, Eva C Schwarz, Andrew M Scott, Christoph Renner, Markus Hoth.   

Abstract

Costimulation is a fundamental principle of T-cell activation. In addition to T-cell receptor engagement, the interaction between CD80 and/or CD86 with CD28 and/or cytotoxic T-lymphocyte antigen 4 (CTLA-4) receptors is required to regulate T-cell activation and tolerance. While the importance of costimulation is clearly established, the exact molecular mechanism is unknown. We demonstrate that T-cell proliferation and the ability of CD8(+) T-effector cells to kill were enhanced slightly by CD80 but dramatically by CD86 costimulation. To further analyse the cellular process of costimulation, we developed a single-cell assay to analyse Ca(2+) signals following costimulation with bi-specific antibodies. We found that this stimulation method worked in every human T-cell that was analysed, making it one of the most efficient T-cell activation methods to date for primary human T cells. The enhanced proliferation and killing by costimulation was paralleled by an increase of Ca(2+) influx following CD86 costimulation and it was dependent on CD28/CTLA-4 expression. The enhanced Ca(2+) influx following CD86 costimulation was abrogated by an antibody that interfered with CD28 function. The differences in Ca(2+) influx between CD80 and CD86 costimulation were not dependent on the depletion of Ca(2+) stores but were eliminated by the application of 10 mum 2-aminoethyldiphenyl borate which has recently been shown to enhance stromal interaction molecule 2 (STIM2)-dependent Ca(2+) entry while reducing STIM1-dependent Ca(2+) entry. Our data indicate that differences in the efficiency of costimulation are linked to differences in Ca(2+) entry.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19824921      PMCID: PMC2807484          DOI: 10.1111/j.1365-2567.2009.03155.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  59 in total

1.  Anti-CD28 has a potent adjuvant effect on the antibody response to soluble antigens mediated through CTLA-4 by-pass.

Authors:  Jennifer Carlring; Tom A Barr; Anne-Marie Buckle; Andrew W Heath
Journal:  Eur J Immunol       Date:  2003-01       Impact factor: 5.532

2.  Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25+ regulatory T cells.

Authors:  Claire N Manzotti; Helen Tipping; Laura C A Perry; Karen I Mead; Patrick J Blair; Yong Zheng; David M Sansom
Journal:  Eur J Immunol       Date:  2002-10       Impact factor: 5.532

Review 3.  Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity.

Authors:  Lieping Chen
Journal:  Nat Rev Immunol       Date:  2004-05       Impact factor: 53.106

4.  Targeted bioactivity of membrane-anchored TNF by an antibody-derived TNF fusion protein.

Authors:  Stefan Bauer; Nicole Adrian; Barbara Williamson; Con Panousis; Natalie Fadle; Joanna Smerd; Ilknur Fettah; Andrew M Scott; Michael Pfreundschuh; Christoph Renner
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

5.  CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells.

Authors:  Yong Zheng; Claire N Manzotti; Michael Liu; Fiona Burke; Karen I Mead; David M Sansom
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

Review 6.  Transcriptional regulation by calcium, calcineurin, and NFAT.

Authors:  Patrick G Hogan; Lin Chen; Julie Nardone; Anjana Rao
Journal:  Genes Dev       Date:  2003-09-15       Impact factor: 11.361

Review 7.  The B7 family and cancer therapy: costimulation and coinhibition.

Authors:  Xingxing Zang; James P Allison
Journal:  Clin Cancer Res       Date:  2007-09-15       Impact factor: 12.531

8.  Calcium dependence of T cell proliferation following focal stimulation.

Authors:  Eva C Schwarz; Carsten Kummerow; Anna S Wenning; Kerstin Wagner; Anne Sappok; Katherina Waggershauser; Désirée Griesemer; Bettina Strauss; Melodie-Jo Wolfs; Ariel Quintana; Markus Hoth
Journal:  Eur J Immunol       Date:  2007-10       Impact factor: 5.532

9.  Potent inhibition of Ca2+ release-activated Ca2+ channels and T-lymphocyte activation by the pyrazole derivative BTP2.

Authors:  Christof Zitt; Bettina Strauss; Eva C Schwarz; Nicola Spaeth; Georg Rast; Armin Hatzelmann; Markus Hoth
Journal:  J Biol Chem       Date:  2004-01-12       Impact factor: 5.157

10.  Topological requirements and signaling properties of T cell-activating, anti-CD28 antibody superagonists.

Authors:  Fred Lühder; Yun Huang; Kevin M Dennehy; Christine Guntermann; Ingrid Müller; Erna Winkler; Thomas Kerkau; Shinji Ikemizu; Simon J Davis; Thomas Hanke; Thomas Hünig
Journal:  J Exp Med       Date:  2003-04-21       Impact factor: 14.307

View more
  17 in total

Review 1.  Unraveling STIM2 function.

Authors:  Esther López; Ginés M Salido; Juan A Rosado; Alejandro Berna-Erro
Journal:  J Physiol Biochem       Date:  2012-04-03       Impact factor: 4.158

2.  The bullseye synapse formed between CD4+ T-cell and staphylococcal enterotoxin B-pulsed dendritic cell is a suppressive synapse in T-cell response.

Authors:  Wei Lin; Zhichao Fan; Yuanzhen Suo; Yuting Deng; Min Zhang; Jiyang Wang; Xunbin Wei; Yiwei Chu
Journal:  Immunol Cell Biol       Date:  2014-10-07       Impact factor: 5.126

3.  P2X7 receptor antagonism prevents IL-1β release from salivary epithelial cells and reduces inflammation in a mouse model of autoimmune exocrinopathy.

Authors:  Mahmoud G Khalafalla; Lucas T Woods; Jean M Camden; Aslam A Khan; Kirsten H Limesand; Michael J Petris; Laurie Erb; Gary A Weisman
Journal:  J Biol Chem       Date:  2017-08-10       Impact factor: 5.157

4.  Fus1/Tusc2 is a novel regulator of mitochondrial calcium handling, Ca2+-coupled mitochondrial processes, and Ca2+-dependent NFAT and NF-κB pathways in CD4+ T cells.

Authors:  Roman Uzhachenko; Sergey V Ivanov; Wendell G Yarbrough; Anil Shanker; Ruslan Medzhitov; Alla V Ivanova
Journal:  Antioxid Redox Signal       Date:  2014-02-04       Impact factor: 8.401

5.  A proteomic view at T cell costimulation.

Authors:  Rudolf Lichtenfels; Gunter Rappl; Andreas A Hombach; Christian V Recktenwald; Sven P Dressler; Hinrich Abken; Barbara Seliger
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

6.  A quantitative assessment of costimulation and phosphatase activity on microclusters in early T cell signaling.

Authors:  J Joris Witsenburg; Heike Glauner; Jörg P Müller; Johannes M M Groenewoud; Günter Roth; Frank-Dietmar Böhmer; Merel J W Adjobo-Hermans; Roland Brock
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

7.  T Cells of Infants Are Mature, but Hyporeactive Due to Limited Ca2+ Influx.

Authors:  Kristin Schmiedeberg; Hardy Krause; Friedrich-Wilhelm Röhl; Roland Hartig; Gerhard Jorch; Monika C Brunner-Weinzierl
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240

8.  Infectious Sporozoites of Plasmodium berghei Effectively Activate Liver CD8α+ Dendritic Cells.

Authors:  Rajesh Parmar; Hardik Patel; Naveen Yadav; Ritika Parikh; Khyati Patel; Aditi Mohankrishnan; Vishakha Bhurani; Urja Joshi; Sarat Kumar Dalai
Journal:  Front Immunol       Date:  2018-02-08       Impact factor: 7.561

9.  Morphological change of CD4(+) T cell during contact with DC modulates T-cell activation by accumulation of F-actin in the immunology synapse.

Authors:  Wei Lin; Yuanzhen Suo; Yuting Deng; Zhichao Fan; Yijie Zheng; Xunbin Wei; Yiwei Chu
Journal:  BMC Immunol       Date:  2015-08-26       Impact factor: 3.615

10.  Barcoding T cell calcium response diversity with methods for automated and accurate analysis of cell signals (MAAACS).

Authors:  Audrey Salles; Cyrille Billaudeau; Arnauld Sergé; Anne-Marie Bernard; Marie-Claire Phélipot; Nicolas Bertaux; Mathieu Fallet; Pierre Grenot; Didier Marguet; Hai-Tao He; Yannick Hamon
Journal:  PLoS Comput Biol       Date:  2013-09-26       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.